Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.

about

Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

P2860

Q37216236-DA4C1711-B4EB-4F7A-972A-20880FA18E2D

P2860

Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.

Item

http://www.wikidata.org/entity/Q35561803

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@ast

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@en

type

Item

label

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@ast

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@en

prefLabel

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@ast

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@en

P1476

Lower dose of antithymocyte gl ...... opoietic stem cell transplant.

@en

P2093

Amy S Ruppert

http://www.w3.org/2001/XMLSchema#string

Craig C Hofmeister

http://www.w3.org/2001/XMLSchema#string

Don M Benson

http://www.w3.org/2001/XMLSchema#string

Galena Salem

http://www.w3.org/2001/XMLSchema#string

Leslie Andritsos

http://www.w3.org/2001/XMLSchema#string

Patrick Elder

http://www.w3.org/2001/XMLSchema#string

Rebecca Klisovic

http://www.w3.org/2001/XMLSchema#string

Sam Penza

http://www.w3.org/2001/XMLSchema#string

Samantha Jaglowski

http://www.w3.org/2001/XMLSchema#string

Steven M Devine

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

P304

1058-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2014.956314

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25166008

http://www.w3.org/2001/XMLSchema#string

P932

4417073

http://www.w3.org/2001/XMLSchema#string

Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.

about

P2860

P2860

Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932